Published in Stem Cells Transl Med on January 27, 2016
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Human embryonic stem cells derived by somatic cell nuclear transfer. Cell (2013) 5.91
Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature (2007) 5.56
Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A (2001) 4.07
Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome. Genome Res (2010) 3.94
Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol (2004) 3.76
Offspring from oocytes derived from in vitro primordial germ cell-like cells in mice. Science (2012) 3.03
Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood (2008) 3.01
Transcriptional silencing of {gamma}-globin by BCL11A involves long-range interactions and cooperation with SOX6. Genes Dev (2010) 2.93
Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature (2012) 2.64
Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol Med (2009) 2.57
Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood (2008) 2.24
Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med (2010) 2.08
Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol (2002) 2.03
The multifunctional role of EKLF/KLF1 during erythropoiesis. Blood (2011) 1.93
Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine. Haematologica (2010) 1.79
Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis. Proc Natl Acad Sci U S A (2008) 1.75
Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation. Transfusion (2010) 1.56
Transfusion to blood group A and O patients of group B RBCs that have been enzymatically converted to group O. Transfusion (2000) 1.49
Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Res (2011) 1.48
Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells. PLoS One (2013) 1.43
The aging population poses a global challenge for blood services. Transfusion (2009) 1.34
Scalable generation of universal platelets from human induced pluripotent stem cells. Stem Cell Reports (2014) 1.25
Generation of red blood cells from human induced pluripotent stem cells. Stem Cells Dev (2011) 1.25
Production of embryonic and fetal-like red blood cells from human induced pluripotent stem cells. PLoS One (2011) 1.19
Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges. Transfus Med Rev (2011) 1.17
Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes. Exp Hematol (2013) 1.16
Technological overview of iPS induction from human adult somatic cells. Curr Gene Ther (2013) 1.13
Human induced pluripotent stem cells can reach complete terminal maturation: in vivo and in vitro evidence in the erythropoietic differentiation model. Haematologica (2012) 1.09
Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells. Biomaterials (2011) 1.04
In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells. Transfusion (2008) 0.98
Universal red blood cells--enzymatic conversion of blood group A and B antigens. Transfus Clin Biol (2004) 0.97
Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease? Transfusion (2012) 0.95
Poly(ADP-ribose) polymerase 1 regulates nuclear reprogramming and promotes iPSC generation without c-Myc. J Exp Med (2012) 0.95
Qualitative and quantitative comparison of the proteome of erythroid cells differentiated from human iPSCs and adult erythroid cells by multiplex TMT labelling and nanoLC-MS/MS. PLoS One (2014) 0.93
Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants. Transplantation (2007) 0.92
Modulating the red cell membrane to produce universal/stealth donor red cells suitable for transfusion. Vox Sang (2007) 0.90
Generation of genome integration-free induced pluripotent stem cells from fibroblasts of C57BL/6 mice without c-Myc transduction. J Biol Chem (2010) 0.90
Generation of megakaryocytic progenitors from human embryonic stem cells in a feeder- and serum-free medium. PLoS One (2013) 0.90
Extensive ex vivo expansion of functional human erythroid precursors established from umbilical cord blood cells by defined factors. Mol Ther (2013) 0.90
Functional inactivation of white blood cells by Mirasol treatment. Transfusion (2006) 0.89
HLA-universal platelet transfusions prevent platelet refractoriness in a mouse model. Hum Gene Ther (2013) 0.88
Erythrocytes from GGTA1/CMAH knockout pigs: implications for xenotransfusion and testing in non-human primates. Xenotransplantation (2014) 0.85
Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment. Transfusion (2009) 0.82
In-vitro stem cell derived red blood cells for transfusion: are we there yet? Yonsei Med J (2014) 0.82
Inhibition of DNA topoisomerase II selectively reduces the threat of tumorigenicity following induced pluripotent stem cell-based myocardial therapy. Stem Cells Dev (2014) 0.81
Leukoreduction and ultraviolet treatment reduce both the magnitude and the duration of the HLA antibody response. Transfusion (2013) 0.78
Transdifferentiation of Human Hair Follicle Mesenchymal Stem Cells into Red Blood Cells by OCT4. Stem Cells Int (2015) 0.77
Preparation of transfusable red cells by enzymatic conversion. Prog Clin Biol Res (1984) 0.76